Outcomes of patients referred through GERS for MREH glaucoma assessment and where the outcome is known
| N | % (95% CI) | |||
| Monitor without treatment | 153/283 | 54.1 (47.9 to 59.4)% | ||
| OHT | 18 | 11.8% | ||
| PACS | 13 | 8.5% | ||
| Suspect | 122 | 79.7% | ||
| Monitor with treatment | 78/283 | 27.6 (22.6 to 33.0)% | ||
| Glaucoma | 42 | 53.8% | ||
| OHT | 13 | 16.7% | ||
| PAC/S | 13 | 24.4% | ||
| Suspect | 4 | 5.1% | ||
| Further investigations required (eg, day phasing) | 9/283 | 3.2 (1.7 to 5.9)% | ||
| Glaucoma | 3 | 33.3% | ||
| Suspect | 6 | 66.7% | ||
| Did not attend | 24/307 | 7.8% | ||
| Discharge | 44/283 | 15.5 (11.8 to 20.2)% | ||
There was no significant difference (p=0.31, χ2 test) across optometric practices when comparing the FP rate. Percentages with exact binomial CIs exclude non-attenders.
GERS, Glaucoma Enhanced Referral Scheme;MREH, Manchester Royal Eye Hospital;OHT, ocular hypertension;PAC, primary angle closure;PAC/S, primary angle closure suspect.